These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10757035

  • 21. Therapeutic potential of natural human tumor necrosis factor-alpha in combination with natural human interferon-alpha or -gamma on human cancer cells.
    Shiiki S, Fuchimoto S, Orita K.
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):345-51. PubMed ID: 3141998
    [Abstract] [Full Text] [Related]

  • 22. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R.
    J Immunol; 2009 Oct 01; 183(7):4782-91. PubMed ID: 19748990
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 01; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
    Narla RK, Chen CL, Dong Y, Uckun FM.
    Clin Cancer Res; 2001 Jul 01; 7(7):2124-33. PubMed ID: 11448932
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG, Garofalo AS, Travassos LR.
    Cytokines Cell Mol Ther; 2002 Jul 01; 7(3):107-16. PubMed ID: 12850810
    [Abstract] [Full Text] [Related]

  • 29. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
    Shiau AL, Lin CY, Tzai TS, Wu CL.
    Cancer Gene Ther; 2001 Jan 01; 8(1):73-81. PubMed ID: 11219496
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
    Clemons KV, Lutz JE, Stevens DA.
    Antimicrob Agents Chemother; 2001 Mar 01; 45(3):686-9. PubMed ID: 11181343
    [Abstract] [Full Text] [Related]

  • 35. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.
    Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line.
    Buessow SC, Gillespie GY.
    J Biol Response Mod; 1984 Dec 01; 3(6):653-62. PubMed ID: 6439829
    [Abstract] [Full Text] [Related]

  • 38. Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo.
    Cesano A, Visonneau S, Rovera G, Santoli D.
    Anticancer Res; 1997 Dec 01; 17(3C):1887-92. PubMed ID: 9216640
    [Abstract] [Full Text] [Related]

  • 39. Combination effects of gamma-interferon with pinyanmycin or psoralen on tongue cancer HSC3 cell line in vitro and in vivo.
    Wu J, Situ Z, Wang W, Chen J, Liu B.
    Chin Med J (Engl); 1995 Apr 01; 108(4):278-81. PubMed ID: 7540529
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.